Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia

Br J Haematol. 2017 Apr;177(2):328-330. doi: 10.1111/bjh.14063. Epub 2016 Mar 31.

Authors

Shaun Fleming¹, Doen Ming Ong¹, Kathryn Jackson², Sharon Avery¹, Peter Mollee³, Paula Marlton³, Glen Kennedy⁴, Andrew H Wei^{1

5}

Affiliations

¹ Department of Haematology, Alfred Hospital, Melbourne, Australia.
² Department of Haematology, Nambour General Hospital, Nambour, Australia.
³ Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia.
⁴ Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, Australia.
⁵ Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.

PMID: 27029236
DOI: 10.1111/bjh.14063

No abstract available

Keywords: AML; acute leukaemia; prognostic factors; residual disease.

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Drug Resistance, Neoplasm
Humans
Induction Chemotherapy
Leukemia, Myeloid, Acute / drug therapy*
Leukemia, Myeloid, Acute / mortality
Leukemia, Myeloid, Acute / pathology
Prognosis
Treatment Outcome